Non-destructive testing of rock bolts using guided ultrasonic waves

The research outlined in this paper is aimed at the development of a portable non-destructive testing instrument for evaluating the condition of rock bolts. In applications such as coal mine roof reinforcement, the opportunities for rock bolt inspection are currently limited to destructive techniques such as the pull-out test. It is proposed that guided ultrasonic waves can be used to solve this inspection problem, using a pulse-echo test carried out from the free end of the bolt. Suitable test frequencies have been identified through the use of modelling software, and successful laboratory and site trials have been undertaken. The research has shown that the proposed approach is capable of determining the bolt length, and of identifying major defects such as necking, deformation, and loss of resin encapsulation.     

DNA methylation and developmental genes in lymphomagenesis--more questions than answers?

There is now considerable evidence suggesting that alterations in the DNA methylating machinery play an important role in tumorigenesis and tumour progression. For example, focal hypermethylation and generalised genomic demethylation are features of many different types of neoplasms. It is thought that tumorigenesis and tumour progression may be caused by hypermethylation induced mutational events and silencing of genes which control cellular proliferation and/or demethylation induced reactivation of genes which may only be required during embryological development. Consequently, we have begun to investigate the role of DNA methylation and developmental genes in malignant lymphoproliferative diseases. Previously, in all cases of non-Hodgkins lymphoma and leukemia studied, we have shown that the myogenic developmental gene Myf-3 is abnormally hypermethylated. In this review we discuss the possible significance of these findings since in vitro studies suggest that Myf-3 may play an important role in control of the cell cycle and therefore lymphomagenesis. In vitro and in vivo evidence suggests that PAX genes may also have oncogenic potential. The PAX family of developmental genes are involved in cellular differentiation, proliferation and cell migration. Expression of PAX3 in particular is associated with cellular mobility. Our previous studies have indicated that alternate regional expression of PAX genes may be controlled by DNA methylation. Therefore, we have proposed that abnormal methylation profiles of PAX3 may be associated with neoplastic transformation and/or metastatic potential. Results thus far reveal that the paired box of PAX3 is abnormally hypermethylated and the homeobox abnormally hypomethylated in lymphomas and leukemias. These new findings are consistent with our postulate and support the idea that inappropriate methylation induced activation or inactivation of developmental genes such as Myf-3 and PAX3 play an important role in lymphomagenesis and disease progression and that inspection of the methylation status of other developmental genes is warranted.     

Developing a comprehensive maltreatment intervention program

A questionnaire was sent to a one in five sample (68 GPs) of General Practitioners (GPs) in Argyll and Clyde Health Board to determine attitudes to standard setting in hypertension and the response rate was 80.7% (55 GPs). Thirty-six GPs (65.4%) stated that they would be interested in sharing care with a consultant who had an interest in the subject and 27 GPs (49.1%) stated that they would be interested in taking part in an educational audit of their hypertensive patients. The results of the study suggest that it would be possible to obtain broad agreement among GPs on standards for diagnosis, treatment and appropriate indications for hospital referral in the management of hypertension but in order to develop consensus further it would be necessary to carry out a more detailed study using a larger cohort of GPs.